Ganciclovir-Resistant Cytomegalovirus Infection in Abdominal Solid Organ Transplant Recipients: Case Series and Review of the Literature-Reference-Cited by-同舟云学术

Ganciclovir-Resistant Cytomegalovirus Infection in Abdominal Solid Organ Transplant Recipients: Case Series and Review of the Literature

Published:2017-09-03 Issue:10 Volume:37 Page:1258-1271
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Rolling Katherine E.¹,Jorgenson Margaret R.²,Descourouez Jillian L.²,Mandelbrot Didier A.³,Redfield Robert R.⁴,Smith Jeannina A.³

Affiliation:

1. University of Wisconsin-Madison School of Pharmacy; Madison Wisconsin

2. Department of Pharmacy; University of Wisconsin Hospital and Clinics; Madison Wisconsin

3. Department of Medicine; University of Wisconsin-Madison School of Medicine and Public Health; University of Wisconsin Hospital and Clinics; Madison Wisconsin

4. Department of Surgery; University of Wisconsin-Madison School of Medicine and Public Health; Madison Wisconsin

Publisher

Wiley

Subject

Pharmacology (medical)

Reference80 articles.

1. Infection in organ-transplant recipients;Fishman;N Engl J Med,1998

2. Antiviral drug resistance of human cytomegalovirus;Lurain;Clin Microbiol Rev,2010

3. Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis;Boivin;J Clin Virol,2012

4. Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory cytomegalovirus infection;Avery;Transplantation,2016

5. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study;Young;Transpl Infect Dis,2016

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance;Clinical Transplantation;2024-09

2. Low-Dose Valganciclovir Prophylaxis Against Cytomegalovirus in Intermediate-Risk Liver and Dual-Abdominal Transplant Recipients;Annals of Pharmacotherapy;2024-05-27

3. A call for cytomegalovirus stewardship initiatives in cardiothoracic transplant;JHLT Open;2024-05

4. Opportunities for Antimicrobial Stewardship Interventions Among Solid Organ Transplant Recipients;Infectious Disease Clinics of North America;2023-09

5. Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis;Journal of Clinical Medicine;2023-08-09